Gene: RRAD
Official Full Name: RRAD, Ras related glycolysis inhibitor and calcium channel regulatorprovided by HGNC
Gene Summary: Predicted to enable GTP binding activity and calcium channel regulator activity. Predicted to be involved in small GTPase-mediated signal transduction. Predicted to be located in T-tubule. Predicted to be active in plasma membrane. Implicated in type 2 diabetes mellitus. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35573 | RRAD Knockout cell line (HCT 116) | Human | RRAD | 1:2~1:4 | Negative | Online Inquiry |
KO35574 | RRAD Knockout cell line (A549) | Human | RRAD | 1:3~1:4 | Negative | Online Inquiry |
RRAD Gene Knockout Cell Lines are specifically engineered cell lines in which the RRAD gene has been inactivated. These cell lines serve as a valuable tool for researchers investigating the functions and pathways associated with the RRAD gene, a member of the Ras superfamily of small GTPases that has been implicated in various cellular processes including cell proliferation, differentiation, and survival. Utilizing advanced CRISPR-Cas9 gene editing technology, our RRAD knockout models facilitate precise modifications, allowing for comprehensive studies on the gene's role in cancer progression, cardiovascular diseases, and neurological disorders.
The core function of RRAD Gene Knockout Cell Lines lies in their ability to provide insights into the signaling pathways regulated by the RRAD protein. By removing the RRAD gene, researchers can observe the resultant phenotypic changes, gene expression alterations, and modified cellular behaviors. Moreover, these knockout lines enable controlled experimental settings to elucidate the gene's contribution to various biological phenomena, offering a deeper understanding of its relevance in pathophysiological contexts.
In research and clinical applications, the RRAD knockout cell lines stand out due to their ability to model diseases more accurately and dissect the molecular mechanisms underlying RRAD-related disorders. This specificity provides an advantage over traditional cell lines, which may express both the target gene and its wild-type counterpart.
Our RRAD Gene Knockout Cell Lines are an invaluable resource for both bench scientists and clinicians engaged in fundamental research and translational studies. They offer unique advantages, such as reproducibility in experimental outcomes and the potential for high-throughput screening applications. By adopting this advanced biological product, researchers can expedite their inquiries, potentially leading to breakthroughs in therapeutic strategies and drug development.
As a leader in the field of genetic engineering, our company is dedicated to providing top-tier biological products that support rigorous scientific research and help drive advancements in molecular biology and medicine. Our expertise in cell line development guarantees the quality and reliability of our RRAD Gene Knockout Cell Lines, ensuring that researchers receive only the best tools to facilitate their studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.